medica 16 has been researched along with triiodothyronine in 2 studies
| Studies (medica 16) | Trials (medica 16) | Recent Studies (post-2010) (medica 16) | Studies (triiodothyronine) | Trials (triiodothyronine) | Recent Studies (post-2010) (triiodothyronine) |
|---|---|---|---|---|---|
| 35 | 0 | 4 | 26,247 | 861 | 3,473 |
| Protein | Taxonomy | medica 16 (IC50) | triiodothyronine (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0006 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0006 | |
| Proliferating cell nuclear antigen | Homo sapiens (human) | 3.6 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0031 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.4109 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Tana, J; Hertz, R; Kalderon, B | 1 |
| Bar-Tana, J; Berman, B; Hermesh, O; Kalderon, B | 1 |
2 other study(ies) available for medica 16 and triiodothyronine
| Article | Year |
|---|---|
Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acid.
Topics: Animals; Cytosol; Energy Metabolism; Glyceric Acids; Glycerophosphates; Hypolipidemic Agents; Liver; Male; Myocardium; Oxidation-Reduction; Palmitic Acids; Phosphates; Rats; Triiodothyronine | 1992 |
Mitochondrial protonophoric activity induced by a thyromimetic fatty acid analogue.
Topics: Animals; Hyperthyroidism; Hypolipidemic Agents; Hypothyroidism; Ion Channels; Male; Membrane Proteins; Methimazole; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Palmitic Acids; Proton-Motive Force; Rats; Triiodothyronine; Uncoupling Agents | 2000 |